COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS) (LANA-FXII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04278885
Recruitment Status : Not yet recruiting
First Posted : February 20, 2020
Last Update Posted : February 20, 2020
Shire International GmbH
Information provided by (Responsible Party):
Karoline Krause, Charite University, Berlin, Germany

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : November 2021